Literature DB >> 6743076

Variability of visual field measurements in normal subjects and patients with retinitis pigmentosa.

D F Ross, G A Fishman, L D Gilbert, R J Anderson.   

Abstract

Twenty-one normal subjects and 26 patients with retinitis pigmentosa (RP) underwent Goldmann perimetry to ascertain both interexaminer and intraexaminer variability. The data are of value for monitoring the natural disease progression in patients with RP and for defining the tolerance limits of field variability in normal subjects.

Entities:  

Mesh：

Year:  1984        PMID： 6743076     DOI： 10.1001/archopht.1984.01040030806021

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


  33 in total

1.  Relationship between foveal cone structure and clinical measures of visual function in patients with inherited retinal degenerations.

Authors:  Kavitha Ratnam; Joseph Carroll; Travis C Porco; Jacque L Duncan; Austin Roorda
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

2.  Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss.

Authors:  Collin Rozanski; Jennifer A Haythornthwaite; Gislin Dagnelie; Ava K Bittner
Journal:  Med Hypotheses       Date:  2014-05-09       Impact factor: 1.538

3.  Variability and Errors of Manually Digitized Goldmann Visual Fields.

Authors:  Michael P Barry; Ava K Bittner; Liancheng Yang; Rebecca Marcus; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Optom Vis Sci       Date:  2016-07       Impact factor: 1.973

4.  Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.

Authors:  Ava K Bittner; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

5.  Vision test variability in retinitis pigmentosa and psychosocial factors.

Authors:  Ava K Bittner; Mohamed A Ibrahim; Jennifer A Haythornthwaite; Marie Diener-West; Gislin Dagnelie
Journal:  Optom Vis Sci       Date:  2011-12       Impact factor: 1.973

6.  Bilateral Concordance of the Fundus Hyperautofluorescent Ring in Typical Retinitis Pigmentosa Patients.

Authors:  Tharikarn Sujirakul; Richard Davis; Deniz Erol; Lijuan Zhang; Giuseppe Schillizzi; Leticia Royo-Dujardin; Sherry Shen; Stephen Tsang
Journal:  Ophthalmic Genet       Date:  2013-10-10       Impact factor: 1.803

7.  Coping strategies to manage stress related to vision loss and fluctuations in retinitis pigmentosa.

Authors:  Ava K Bittner; Lori Edwards; Maureen George
Journal:  Optometry       Date:  2010-06-29

8.  Variable phenotypic expressivity in a Swiss family with autosomal dominant retinitis pigmentosa due to a T494M mutation in the PRPF3 gene.

Authors:  Veronika Vaclavik; Marie-Claire Gaillard; L Tiab; Daniel F Schorderet; Francis L Munier
Journal:  Mol Vis       Date:  2010-03-19       Impact factor: 2.367

9.  Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.

Authors:  Francesco Testa; Albert M Maguire; Settimio Rossi; Eric A Pierce; Paolo Melillo; Kathleen Marshall; Sandro Banfi; Enrico M Surace; Junwei Sun; Carmela Acerra; J Fraser Wright; Jennifer Wellman; Katherine A High; Alberto Auricchio; Jean Bennett; Francesca Simonelli
Journal:  Ophthalmology       Date:  2013-03-06       Impact factor: 12.079

10.  Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

Authors:  Francesca Simonelli; Albert M Maguire; Francesco Testa; Eric A Pierce; Federico Mingozzi; Jeannette L Bennicelli; Settimio Rossi; Kathleen Marshall; Sandro Banfi; Enrico M Surace; Junwei Sun; T Michael Redmond; Xiaosong Zhu; Kenneth S Shindler; Gui-Shuang Ying; Carmela Ziviello; Carmela Acerra; J Fraser Wright; Jennifer Wellman McDonnell; Katherine A High; Jean Bennett; Alberto Auricchio
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.